InsidersTradesSigma
Xbrane Biopharma AB Stock: price and directors' dealings · Finland · FIN-FSA
Follow the Xbrane Biopharma AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Xbrane Biopharma AB has logged 1 public disclosures. Market capitalisation: €227.7m. The latest transaction was reported on 28 October 2025 (Sale). Among the most active insiders: Siavash Bashiri. The full history is openly available.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€4,647
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Xbrane Biopharma AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 15.00.
35Σ signal
Fundamental score
Ranked 10,740 of 26,212 companies
56.6
score / 100
Value50
Quality63
FCF yld-174%
Earn yld57%
EV/EBITDA·
ROE-20%
Gross mgn59%
Net mgn83%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 28 October 2025
Declarations1 total
4,976 shares@ €0.93380.0020% mcap100.0% of flowAktieFI:A003T195-1
1 of 1 declaration